Swedish Biomimetics 3000® Ltd (SB3000) are looking forward to presenting at the TIDES Oligonucleotide and Peptide Therapeutics Conference, 30 April – 3 May 2017, which is to be held at the Manchester Grand Hyatt, San Diego, California.
This conference is the largest meeting to accelerate Oligonucleotide and Peptide products from early discovery to late-stage development and commercialisation.
Kimon Roussopoulos, Ph.D., Head of Research and Development, SB3000, will present:
‘The Application of Assembly Line Methodologies to the Development and Manufacture of Complex Synthetic Oligomers’ on 2nd May at 09:30. The abstract says:
“Swedish Biomimetics has developed and proven μLOT®, the world’s first continuous multi- stage peptide synthesis technology. It offers scope for faster development, lower cost of goods and a simplified regulatory approval process. This will be the first public presentation of this technology, whose potential has already generated significant commercial interest.”
Here are useful links to the TIDES 2017 website:
If you have any questions about the presentation by SB3000, please get in touch with: